The Indianapolis Recorder > News > Local > Lilly licenses PDL type …
By solostream on Dec 21, 2009 with Comments 0
PDL said Lilly and its partner MacroGenics are studying teplizumab as a treatment for newly diagnosed type 1 diabetes . Lilly will pay PDL fees during testing of teplizumab, and will pay royalties on sales if the drug is approved. …
Here is the original:
The Indianapolis Recorder > News > Local > Lilly licenses PDL type …
Filed Under: T1 Info
